Sfoglia per AUTORE
PIGNATA S
Collezione AO Ordine Mauriziano

  

Items : 33

2025
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Romeo M; Ilieva R; Timcheva C; Di Maio M; Bashir Z; Taylor R; Barnicle A; Clamp A;

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;203:114039. doi: 10.1016/j.ejca.2024.114039. Epub 2024 Mar 30.
2024
AO Ordine Mauriziano

Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Cioffi R; Borsotti L; Bellero M; Rognone C; Carbone V; Ferrandina G; Mantiero M; Azzolina C; Geninatti E; Pignata S; Valabrega G;

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jul;35(7):667-676. doi: 10.1016/j.annonc.2024.04.007. Epub 2024 May 3.
2024
AO Ordine Mauriziano

Pignata S; Califano D; Lorusso D; Arenare L; Bartoletti M; De Giorgi U; Andreetta C; Pisano C; Scambia G; Lombardi D; Farolfi A; Cinieri S; Passarelli A; Salutari V; De Angelis C; Mignogna C; Priolo D; Capoluongo ED; Tamberi S; Scaglione GL; Arcangeli V; De Cecio R; Scognamiglio G; Greco F; Spina A; Turinetto M; Russo D; Carbone V; Casartelli C; et alii...

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial. in The International journal of biological markers / Int J Biol Markers. 2024 Dec;39(4):328-337. doi: 10.1177/03936155241296164. Epub 2024 Nov 8.
2024
AO Ordine Mauriziano

Indraccolo S; Signoriello S; Piga I; Esposito G; Ferrarini F; Boscolo Bragadin A; Salutari V; Pisano C; Califano D; Bignotti E; Tognon G; Simeon V; Artioli G; Ferrero A; Cinieri S; Bologna A; Chiodini P; Scognamiglio G; Bottoni C; Spina A; Russo D; Arenare L; Perrone F; Pignata S;

Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society. in Tumori / Tumori. 2023 Oct;109(5):490-495. doi: 10.1177/03008916221146820. Epub 2023 Jan 6.
2023
ASL Torino 5
AO Ordine Mauriziano

Artioli G; Valabrega G; Purro A; Mammoliti S; Testa S; Scotto G; Turinetto M; Bellero M; Milani A; Tuninetti V; Pignata S; Biglia N; Scandurra G; Mangili G; Di Maio M; De Giorgi U; Savarese A; Castaldo D; Lorusso D;

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.
2023
AO Ordine Mauriziano

Anpalakhan S; Signori A; Cortellini A; Verzoni E; Giusti R; Aprile G; Ermacora P; Catino A; Pipitone S; Di Napoli M; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Schinzari G; Casadei C; Grossi F; Rizzo M; Montesarchio V; Verderame F; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Tondini CA; Camerini A; Banzi MC; et alii...

Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial. in Gynecologic oncology / Gynecol Oncol. 2023 May;172:72-77. doi: 10.1016/j.ygyno.2023.03.011. Epub 2023 Mar 23.
2023
AO Ordine Mauriziano

Musacchio L; Turinetto M; Arenare L; Bartoletti M; Califano D; Tuninetti V; Marchetti C; Cormio G; Loizzi V; Pisano C; Salutari V; Valabrega G; Priolo D; Cecere SC; Ventriglia J; Raspagliesi F; Perrone F; Fagotti A; Lorusso D; Scambia G; Pignata S;

2023
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Marín MR; Ilieva R; Timcheva C; Di Maio M; Blakeley C; Taylor R; Barnicle A; Clamp A;

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer. in Gynecologic oncology / Gynecol Oncol. 2023 Jul;174:80-88. doi: 10.1016/j.ygyno.2023.04.028. Epub 2023 May 9.
2023
AO Ordine Mauriziano

Vergote I; Van Nieuwenhuysen E; Casado A; Laenen A; Lorusso D; Braicu EI; Guerra-Alia E; Zola P; Wimberger P; Debruyne PR; Falcó E; Ferrero A; Muallem MZ; Kerger J; García-Martinez E; Pignata S; Sehouli J; Van Gorp T; Gennigens C; Rubio MJ;

2023
AO Ordine Mauriziano

Bersanelli M; Verzoni E; Cortellini A; Giusti R; Calvetti L; Ermacora P; Di Napoli M; Catino A; Guadalupi V; Guaitoli G; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Perrone F; Maruzzo M; Rossi E; Casadei C; Montesarchio V; Grossi F; Rizzo M; Travagliato Liboria MG; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Camerini A; Sorarù M; et alii...

2023
AO Ordine Mauriziano

Procopio G; Lolli C; Di Napoli M; Pignata S; Ignazzi G; Gamba T; Veccia A; Scandurra G; Hamzaj A; Ermacora P; Masini C; Aieta M; Atzori F; Stellato M; Carella C; Bimbatti D; Giannatempo P; De Giorgi U; Vignani F; Tambaro R; Pierantoni F; Zonno A; Santini D; Di Maio M;

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Borsotti L; Paolini B; Puppo A; Marinaccio M; Cormio G; Carella C; Mandato VD; Parisi A; Sikokis A; Biglia N; Mammoliti S; Zanchi L; Artioli G; Maldi E; Andreetta C; Raspagliesi F; Picardo E; Pignata S; Ghisoni E; Tuninetti V; Scotto G; Turinetto M; Sangiolo D; Di Maio M; Valabrega G;

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Tuninetti V; Picardo E; Vertechy L; Bergamini A; Palaia I; Artioli G; Parisi A; Scandurra G; Scollo P; Baldoni A; Malaguti P; Cassani C; Zamagni C; Pisano C; Ricotti A; Marchetti C; Turinetto M; Scotto G; Scambia G; Pignata S; Valabrega G;

2023
AO Ordine Mauriziano

Colombo N; Gadducci A; Landoni F; Lorusso D; Sabbatini R; Artioli G; Berardi R; Ceccherini R; Cecere SC; Cormio G; De Angelis C; Legge F; Lissoni A; Mammoliti S; Mangili G; Naglieri E; Petrella MC; Ricciardi GRR; Ronzino G; Salutari V; Sambataro D; Savarese A; Scandurra G; Tasca G; Tomao F; Valabrega G; Zavallone L; Pignata S;

Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2024 Jan 22;13:1357793. doi: 10.3389/fonc.2023.1357793. eCollection 2023.
2023
AO Ordine Mauriziano

Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G; Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; et alii...

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2023 Aug 7;13:1232476. doi: 10.3389/fonc.2023.1232476. eCollection 2023.
2023
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. in Frontiers in oncology / Front Oncol. 2023 Sep 14;13:1247291. doi: 10.3389/fonc.2023.1247291. eCollection 2023.
2023
AO Ordine Mauriziano

Arezzo F; Giannone G; Castaldo D; Scotto G; Tuninetti V; Turinetto M; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Loizzi V; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Pembrolizumab as a single agent for patients with MSI-H advanced endometrial carcinoma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Oct;22(10):1039-1047. doi: 10.1080/14737140.2022.2126356. Epub 2022
2022
AO Ordine Mauriziano

Turinetto M; Lombardo V; Pisano C; Musacchio L; Pignata S;

MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. in Cancer treatment reviews / Cancer Treat Rev. 2022 Nov;110:102458. doi: 10.1016/j.ctrv.2022.102458. Epub 2022 Aug 24.
2022
AO Ordine Mauriziano

Musacchio L; Valsecchi AA; Salutari V; Valabrega G; Camarda F; Tuninetti V; Giannone G; Bartoletti M; Marchetti C; Pignata S; Fagotti A; Scambia G; Di Maio M; Lorusso D;

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22). in British journal of cancer / Br J Cancer. 2022 Nov;127(8):1479-1486. doi: 10.1038/s41416-022-01897-1. Epub 2022 Jul 22.
2022
AO Ordine Mauriziano

Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; Ferraù F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

2022
AO Ordine Mauriziano

Procopio G; Losanno T; Naglieri E; Stellato M; Tambaro R; Banna GL; Vignani F; De Giorgi U; Basso U; Maruzzo M; Farè E; Raggi D; Giannatempo P; Mazzaschi G; Bersanelli M; Pignata S; Necchi A; Buti S;

Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2022 Apr;20(2):155-164. doi: 10.1016/j.clgc.2021.12.008. Epub 2021 Dec 16.
2022
AO Ordine Mauriziano

Calabrò F; Losanno T; Caffo O; Veccia A; Roviello G; Vignani F; Santini D; Stellato M; Bersanelli M; Buti S; Naglieri E; Casadei C; De Giorgi U; Banna GL; Lipari H; Maruzzo M; Pierantoni F; Marandino L; Giannatempo P; Raggi D; Mucciarini C; Pignata S; Necchi A; Maio MD;

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma. in Frontiers in oncology / Front Oncol. 2022 Sep 21;12:979519. doi: 10.3389/fonc.2022.979519. eCollection 2022.
2022
AO Ordine Mauriziano

Lorusso D; Danesi R; Locati LD; Masi G; De Giorgi U; Gadducci A; Pignata S; Sabbatini R; Savarese A; Valabrega G; Zamagni C; Colombo N;

Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey. in Frontiers in oncology / Front Oncol. 2022 May 27;12:880008. doi: 10.3389/fonc.2022.880008. eCollection 2022.
2022
AO Ordine Mauriziano

Giannone G; Castaldo D; Tuninetti V; Scotto G; Turinetto M; Valsecchi AA; Bartoletti M; Mammoliti S; Artioli G; Mangili G; Salutari V; Lorusso D; Cormio G; Zamagni C; Savarese A; Di Maio M; Ronzino G; Pisano C; Pignata S; Valabrega G;

Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial. in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society / Int J Gynecol Cancer. 2021 Oct;31(10):1348-1355. doi: 10.1136/ijgc-2021-002786. Epub 2021 Aug 30.
2021
AO Ordine Mauriziano

Gallo C; Schettino C; Gargiulo P; Greggi S; Distefano M; Bogani G; Nardin M; Lapresa M; Cecere SC; Salutari V; Lorusso D; Katsaros D; Lissoni AA; Scollo P; De Giorgi U; Cinieri S; De Censi A; Breda E; Ferrero A; Lauria R; Gadducci A; Tognon G; Artioli G; Frezzini S; Colombo N; Pisano C; Scambia G; Raspagliesi F; Arenare L; et alii...

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7). in American journal of clinical oncology / Am J Clin Oncol. 2021 Mar 1;44(3):121-125. doi: 10.1097/COC.0000000000000791.
2021
AO Ordine Mauriziano

Mini E; Grillone F; Mucciarini C; Fornarini G; Soraru' M; Verzoni E; Sbrana A; Di Lorenzo G; De Vivo R; Bersanelli M; Buti S; Naglieri E; Bimbatti D; Maruzzo M; Casadei C; De Lisi D; Pantano F; De Giorgi U; Stellato M; Santini D; Vignani F; Attademo L; Pignata S; Procopio G;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20
2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...

2020
AO Ordine Mauriziano

Tuninetti V; Di Napoli M; Ghisoni E; Maggiorotto F; Robella M; Scotto G; Giannone G; Turinetto M; Siatis D; Ponzone R; Vaira M; De Simone M; Scaffa C; Pignata S; Greggi S; Di Maio M; Valabrega G;

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Dicorato AM; Verusio C; Giordano P; Gernone A; Prati V; Carnio S; Corbo C; Tassinari D; Cavanna L; Meriggi F; Iannopollo M; Sartori D; Longo L; Pezzuolo D; Bonetti A; Mucciarini C; Bracarda S; Fornarini G; Battelli N; Russo A; Lacidogna G; Zucali PA; Sorarù M; Banzi M; Negrini G; Cinieri S; Fratino L; Zustovich F; Mencoboni M; et alii...

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:87-90. doi: 10.1016/j.critrevonc.2019.05.003. Epub 2019 May 8.
2019
AO Ordine Mauriziano

Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Pignata S; Banna GL;

Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Aug;23(8):2020-2027. doi: 10.1093/annonc/mdr583. Epub 2012 Jan 30.
2012
AO Ordine Mauriziano

Brundage M; Gropp M; Mefti F; Mann K; Lund B; Gebski V; Wolfram G; Reed N; Pignata S; Ferrero A; Brown C; Eisenhauer E; Pujade-Lauraine E;